BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21796764)

  • 1. Early diagnosis improves the quality of life in MYH9 disorder.
    Shiota M; Kunishima S; Hamabata T; Nakata M; Hata D
    Pediatr Blood Cancer; 2012 Feb; 58(2):314-5. PubMed ID: 21796764
    [No Abstract]   [Full Text] [Related]  

  • 2. A rare case of MYH9 disorders presenting with macrothrombocytopenia and deafness caused by MYH9-R702C mutation.
    Kodama R; Taketani T; Kunishima S; Mishima S; Yoshikawa Y; Kanai R; Suyama T; Yoshino I; Kunishi H; Shibata H; Nagai A; Yamaguchi S; Masuda J
    Thromb Res; 2009 Sep; 124(4):508-11. PubMed ID: 19250658
    [No Abstract]   [Full Text] [Related]  

  • 3. Hematologic and genetic characterization of an MYH9-related disorder in a Chinese family.
    Ma ES; Wong CL; Shek TW; Hui SP
    Haematologica; 2006 Jul; 91(7):1002-3. PubMed ID: 16818291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel MYH9 mutation in a patient with May-Hegglin anomaly.
    Otsubo K; Kanegane H; Nomura K; Ogawa J; Miyawaki T; Kunishima S
    Pediatr Blood Cancer; 2006 Dec; 47(7):968-9. PubMed ID: 16642488
    [No Abstract]   [Full Text] [Related]  

  • 5. [A non-familial May-Hegglin anomaly accompanying with MYH9 gene R1933X mutation and I1626V polymorphism].
    Li Y; Wang YW; Zhang GS; Fang MY
    Zhonghua Xue Ye Xue Za Zhi; 2009 Sep; 30(9):577-81. PubMed ID: 19954613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the understanding of MYH9 disorders.
    Kunishima S; Saito H
    Curr Opin Hematol; 2010 Sep; 17(5):405-10. PubMed ID: 20601875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of unique neutrophil non-muscle myosin heavy chain-A localization by immunofluorescence analysis in MYH9 disorder presented with macrothrombocytopenia without leukocyte inclusions and deafness.
    Kunishima S; Matsushita T; Shiratsuchi M; Ikuta T; Nishimura J; Hamaguchi M; Naoe T; Saito H
    Eur J Haematol; 2005 Jan; 74(1):1-5. PubMed ID: 15613099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First description of somatic mosaicism in MYH9 disorders.
    Kunishima S; Matsushita T; Yoshihara T; Nakase Y; Yokoi K; Hamaguchi M; Saito H
    Br J Haematol; 2005 Feb; 128(3):360-5. PubMed ID: 15667538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Description of a novel mutation leading to MYH9-related disease.
    Burt RA; Joseph JE; Milliken S; Collinge JE; Kile BT
    Thromb Res; 2008; 122(6):861-3. PubMed ID: 18676005
    [No Abstract]   [Full Text] [Related]  

  • 10. A unique immunofluorescence method promotes accurate diagnosis in MYH9 disorders: a case report.
    Yoshinari M; Kunishima S; Miyabayashi S; Saito H; Tsuchiya S
    J Pediatr Hematol Oncol; 2004 Sep; 26(9):579-83. PubMed ID: 15342975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of MYH9 disorders caused by a novel mutation (p.K74E).
    Kanematsu T; Suzuki N; Yoshida T; Kishimoto M; Aoki T; Ogawa M; Kagami Y; Kiyoi H; Matsushita T; Kunishima S
    Ann Hematol; 2016 Jan; 95(1):161-163. PubMed ID: 26382273
    [No Abstract]   [Full Text] [Related]  

  • 12. The irreversibility of platelet aggregation is regulated by myosin IIA, but is not compromised in MYH9-related disease.
    Catricalà S; Guidetti GF; Canobbio I; Pecci A; Balduini CL; Balduini C; Torti M
    Thromb Res; 2011 Feb; 127(2):171-3. PubMed ID: 20828798
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification and characterization of the first large deletion of the MYH9 gene associated with MYH9 disorders.
    Kunishima S; Matsushita T; Hamaguchi M; Saito H
    Eur J Haematol; 2008 Jun; 80(6):540-4. PubMed ID: 18284620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A diagnostic approach for inherited thrombocytopenia].
    Pondarre C
    Arch Pediatr; 2007 Jun; 14(6):676-8. PubMed ID: 17419013
    [No Abstract]   [Full Text] [Related]  

  • 15. [Identification of MYH9 gene mutation in a May-Hegglin anomaly family].
    Gao F; Hao JH; Wang ZL
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):660-2. PubMed ID: 23134864
    [No Abstract]   [Full Text] [Related]  

  • 16. Germinal mosaicism in MYH9 disorders: a family with two affected siblings of normal parents.
    Kunishima S; Takaki K; Ito Y; Saito H
    Br J Haematol; 2009 Apr; 145(2):260-2. PubMed ID: 19208103
    [No Abstract]   [Full Text] [Related]  

  • 17. MYH9 related platelet disorders - often unknown and misdiagnosed.
    Althaus K; Najm J; Greinacher A
    Klin Padiatr; 2011 May; 223(3):120-5. PubMed ID: 21567368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the first in cis mutations in MYH9 disorder.
    Miyajima Y; Kunishima S
    Eur J Haematol; 2009 Apr; 82(4):288-91. PubMed ID: 19191864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. May-Hegglin anomaly: morphologic and clinical manifestations.
    Saito H; Kunishima S
    Clin Adv Hematol Oncol; 2009 Feb; 7(2):111-3. PubMed ID: 19367252
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombocytopenia and proteinuria. Nonmuscle myosin heavy-chain-9-related disease ( MYH9 RD) or Epstein syndrome (ES).
    Bhatt A; Broxson E; Witte D; Omoloja A
    Pediatr Nephrol; 2009 Mar; 24(3):485-8. PubMed ID: 18781340
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.